| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 3,200 | ₹4.15 -17% | 1,00033.33% |
| - | - | 3,300 | ₹7.4 -19.12% | 4,75046.15% |
| - | - | 3,350 | ₹12.15 -0.81% | 6,750-3.57% |
| 2500% | ₹233.25 0% | 3,400 | ₹14.95 -9.93% | 25,000-8.25% |
| - | - | 3,450 | ₹20.25 -19% | 13,0001.96% |
| 22,5000% | ₹142 -5.01% | 3,500 | ₹32 -10.36% | 58,50010.90% |
| 37,2500% | ₹103.95 -11.22% | 3,550 | ₹47 -7.38% | 7,25045% |
| 1,41,7504.61% | ₹84.65 -4.51% | 3,600 | ₹67.5 -1.24% | 50,5007.44% |
| 53,2501.42% | ₹64 -1.15% | 3,650 | ₹93.65 -12.31% | 14,500-1.69% |
| 21,75038.09% | ₹44.8 -3.55% | 3,700 | ₹156.15 0% | 4,5000% |
| 16,00016.36% | ₹30.5 -5.13% | 3,750 | - | - |
| 47,500-3.55% | ₹21 -2.77% | 3,800 | ₹219.95 0% | 7500% |
| 5,500-4.34% | ₹15.95 7.04% | 3,850 | - | - |
| 25,75014.44% | ₹9.7 -12.21% | 3,900 | - | - |
| 1,0000% | ₹8.05 0% | 3,950 | - | - |
| 4,500-14.28% | ₹5 -5.66% | 4,000 | ₹399 0% | 2500% |
Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
